Status message

Active context: kki_bg_colors_yellow

Find Expanded Access Drugs

Could an expanded access drug be right for you or your loved one?

If you or a loved one is interested in treatment with an investigational drug under an expanded access protocol listed in, review the protocol eligibility criteria and send a message to the Help Desk. If there is not an expanded access protocol listed in, you or your healthcare provider may contact a manufacturer of an investigational drug directly to ask about expanded access programs.

For additional information on expanded access programs, please see the FDA's Access to Investigational Drugs page.

Expanded access studies can be found by searching on the Advanced Search page on

  1. Select "Expanded Access Studies" from the "Study Type" pull-down menu, and
  2. Press Search.

Or use these links:

Bradley L. Schlaggar, M.D., Ph.D., Named President and CEO of Kennedy Krieger Institute

We’re thrilled to welcome Bradley L. Schlaggar, M.D., Ph.D., to the Kennedy Krieger family as our next President and CEO.

Learn more.


Read inspiring stories, news and updates about the Institute's patient care, research, special education, professional training, and community programs.